BCTX — Briacell Therapeutics Corp

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $3.04 Analyst target: $150.00 Upside: 4834.21%

About Briacell Therapeutics Corp

BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.

See the full interactive analysis & chart →

Informational only — not investment advice.